 GENEVA, Switzerland May 1 6 , 2022 ObsEva SA NASDAQ: OBSV; SIX: OBSN, a biopharmaceutical company developing and commercializing novel therapies for womens health, today announced that Company Management will provide a corporate update at the upcoming H.C. Wainwright Global Investment Conference, taking place virtually and in Miami, Florida from May 23 26, 2022. 